Mangalam Drugs & Organics Limited (NSE:MANGALAM)
29.50
-0.74 (-2.45%)
Apr 7, 2026, 12:05 PM IST
Revenue by Segment
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Source: S&P Global Market Intelligence.